ARTICLE | Company News
GlaxoSmithKline endocrine news
October 25, 2010 7:00 AM UTC
GlaxoSmithKline disclosed in its 3Q10 earnings that it is in the process of responding to a subpoena from the U.S. Department of Justice related to the development and marketing of diabetes drug Avan...